Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 5,610 | 4,230 | 4,210 | 4,670 | 3,490 |
| Gross Profit | 5,610 | 4,230 | 4,210 | 4,670 | 3,490 |
| Operating Expenses | 9,504 | 11,804 | 10,164 | 10,668 | 9,294 |
| Operating Income | -3,894 | -7,574 | -5,954 | -5,998 | -5,804 |
| Other Income | 684 | 284 | 744 | -892 | 494 |
| Pre-tax Income | -3,210 | -7,290 | -5,210 | -6,890 | -5,310 |
| Net Income Continuous | -3,210 | -7,290 | -5,210 | -6,890 | -5,310 |
| Net Income | $-3,210 | $-7,290 | $-5,210 | $-6,890 | $-5,310 |
| EBITDA(a) | $-3,604 | $-7,254 | $-5,614 | $-5,698 | $-5,424 |